Cytochrome P450 17A1 Inhibitor Drug Class List
✉ Email this page to a colleague
Drugs in Drug Class: Cytochrome P450 17A1 Inhibitor
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Janssen Biotech | ZYTIGA | abiraterone acetate | TABLET;ORAL | 202379-001 | Apr 28, 2011 | AB | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Janssen Biotech | ZYTIGA | abiraterone acetate | TABLET;ORAL | 202379-002 | Apr 14, 2017 | AB | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Sun Pharm | YONSA | abiraterone acetate | TABLET;ORAL | 210308-001 | May 22, 2018 | RX | Yes | Yes | 10,292,990 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Sun Pharm | YONSA | abiraterone acetate | TABLET;ORAL | 210308-001 | May 22, 2018 | RX | Yes | Yes | 9,889,144 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Strongbridge | RECORLEV | levoketoconazole | TABLET;ORAL | 214133-001 | Dec 30, 2021 | RX | Yes | Yes | 10,835,530 | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
